Valeant Stock

VRX Stock: Potential Bottom Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock is making headlines once again, and investors are trying to stay on top of these new developments. The newswire is causing some serious volatility in VRX stock and on November 1, 2016, Valeant stock surged higher on the…

What Does VRX Stock's Rally Mean?  Valeant Pharmaceuticals Intl Inc (NYSE:VRX) made an impressive recovery today as VRX stock rose 30% despite the ongoing investigation into two of the company’s former executives. Yesterday, VRX stock looked all but dead after falling 12.02% as a result of a fraud investigation…

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock is plummeting on rumors that U.S. prosecutors are building a fraud case against two former company executives. Valeant stock plunged 12.02% after news of the investigation went public. Former CEO J. Michael Pearson and former CFO Howard Schilling could face charges within weeks. (Source:…

VRX Stock: Bears are in Control As much as I would love to be bullish on Valeant Pharmaceuticals Intl Inc (TSE:VRX) stock, the price chart has served only to reinforce the bearish trend. Even with VRX stock down 90% from the highs, this company has failed to give me…

VRX stock: Bullish Price Action Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock has been a focus of mine for some time because I find it peculiar how people react to stocks that have fallen from great heights. For some reason, the mentality that some investors have toward fallen stocks…

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock, the once-high-flying Wall Street favorite, suffered not just one, but several major blows that knocked the company down to its knees. The Canadian pharmaceutical company struggled and lost more than 87% in stock value over the past year. VRX stock went down from…

Valeant Stock Set to Continue Recovery Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is slowly but surely moving higher. Indeed, if we are to give credence to its CEO Joseph Papa, Valeant stock is poised for a nice recovery by the start of 2017. The bullish argument draws from the fact…

VRX Stock May Face Bumpy Road, but Outlook is Bullish Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has gained almost 14% this week on the New York Stock Exchange. One of the factors contributing to the bullish sentiment over Valeant stock came from Morgan Stanley, which gave it an “overweight”…

VRX Stock: Bull vs. Bear Battle Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock has dominated headlines for some time now. It is unfortunate that recent headlines have been negative and have affected share price. Unless you purchased shares a decade ago, chances are that you are underwater on your…

Investigation is Bad News for Valeant Stock Valeant Pharmaceuticals International Inc (NYSE:VRX) has started climbing again, and what a climb it was! Valeant stock gained 21.69% after releasing earnings on August 8. Valeant stock has since taken a slight—but we expect temporary—beating over legal issues lingering from the…

Has Valeant Stock Bottomed? There’s a cautiously cheerful wind blowing around Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Valeant stock is trading 6.6% higher than a month ago and 15.5% higher than a week ago. In fact, Valeant is back at the level at which it was trading last June,…

This Is No Reason to Sell VRX Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) may have left its worst days behind. Valeant had experienced lows its investors never even considered in their nightmares in mid-June, but VRX stock has gained no less than 22.9% in the past three weeks.…

The Next VRX Stock? Andrew Left of Citron Research is a notorious short seller. He can boast of having been among the first to see that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock was about to collapse, and he has a reputation for finding and shorting the hell out…

Don’t Give Up on VRX Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock dropped almost 15% on June 7 after posting poor results. It could have been much worse. At the very least, after a year of turmoil amid legal and accounting problems, Valeant stock retains some value; it…

No Upside for VRX Stock Take a glance at the daily headlines and you’ll realize that embattled Valeant Pharmaceuticals Intl Inc (NYSE:VRX, TSE:VRX)—the poster child for short sellers and misgivings—continues to be one of the most talked about stocks. The decision to pick up shares of VRX stock…

Is Valeant a Takeover Target? The pharmaceutical giant Pfizer Inc. (NYSE:PFE) has formally given up on acquiring Allergan plc (NYSE:AGN), due to changes in U.S. tax laws. The deal was potentially worth some $160.0 billion, which would have been the biggest deal in the pharmaceutical sector ever. Pfizer…